首页> 外文期刊>The Journal of Urology >Long-term outcome of cadaveric renal transplant after treatment of symptomatic lymphocele.
【24h】

Long-term outcome of cadaveric renal transplant after treatment of symptomatic lymphocele.

机译:有症状的淋巴结肿大后尸体肾移植的长期结果。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Between January 1993 and December 2002 a total of 1,289 renal transplants were performed at our institution. Symptomatic post-transplant lymphocele presenting as increased creatinine and hydronephrosis of the allograft was recorded at 0.02%. Records of the 27 patients in whom symptomatic lymphocele developed and of those who underwent contralateral kidney transplant (control group) were compared to determine the long-term effects of lymphocele formation on allograft function. MATERIALS AND METHODS: A total of 37 procedures for the treatment of lymphocele were performed in 24 patients. Open marsupialization (12) and laparoscopic marsupialization (3) procedures were performed as primary treatments. Two patients underwent repeat open marsupialization. Aspiration and percutaneous catheter drainage were performed as a primary procedure in 7 and 1 cases, respectively. Percutaneous nephrostomy was required in 4 cases before definitive treatment. RESULTS: The mean time to development of a lymphocele was 121 days (range 35 to 631). Symptomatic lymphocele did not require treatment in 3 patients. Of 19 patients undergoing primary marsupialization, recurrence in 2 necessitated repeat surgery. However, aspiration and percutaneous drainage proved to be definitive in only 2 cases. In total 8 patients required more than 1 procedure. At a mean followup of 63 months (SD 30.3) 21 allografts continued to function with a mean serum creatinine of 152 mumol/l (SD 67.9). In the control group 3 patients experienced graft failure and mean serum creatinine was 154 mumol/l (SD 51.9). Five patients died in the lymphocele group, 2 with functioning grafts compared to 4 deaths in the control group. CONCLUSIONS: Surgical marsupialization is the preferred primary treatment for symptomatic lymphocele and is associated with excellent long-term allograft outcome.
机译:目的:在1993年1月至2002年12月期间,我们机构共进行了1,289例肾脏移植。有症状的移植后淋巴球囊肿表现为肌酐增加和同种异体肾积水,记录为0.02%。比较27例有症状的淋巴膨大患者和进行对侧肾移植的患者(对照组)的记录,以确定淋巴膨大形成对同种异体移植功能的长期影响。材料与方法:24例患者共进行了37例淋巴结肿大的治疗。进行开放有袋化(12)和腹腔镜有袋化(3)程序作为主要治疗方法。两名患者进行了重复开放有袋化。分别以7例和1例为主要手术方法,进行抽吸和经皮导管引流。明确治疗前4例需要经皮肾造口术。结果:淋巴膨大的平均发生时间为121天(范围为35至631)。有症状的淋巴结肿大3例无需治疗。在接受原发性有袋化的19例患者中,有2例复发必须进行再次手术。但是,仅2例病例证实了抽吸和经皮引流是确定的。总共有8位患者需要进行1次以上的手术。平均随访63个月(SD 30.3),同种异体移植物继续正常运转21次,平均血清肌酐为152μmol/ l(SD 67.9)。在对照组中,有3例患者发生了移植失败,平均血清肌酐为154μmol/ l(SD 51.9)。淋巴膨出组有5例患者死亡,其中2例具有正常的移植物死亡,而对照组有4例死亡。结论:外科有袋化术是有症状的淋巴膨出术的首选主要治疗方法,并具有良好的长期同种异体移植结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号